Trial intelligence / Profile preview

Calcium Hydroxide vs Triple Antibiotic Paste for Post-Op Pain in Apical Periodontitis

NCT06821763Phase 3

Key facts

Status
Not yet recruiting
Start
May 2025
Primary completion
Oct 2025
Countries
1
Modality
Small Molecules
Conditions
apical periodontitis (AP)
01

Overview

Phase 3, randomised, single-blind trial in apical periodontitis (AP) comparing Calcium Hydroxide with Triple Antibiotic Paste (2 arms). Primary endpoint: Post Operative Pain Severity at 96 hours. Planned start May 2025; status: not yet recruiting.

02

Design

2 arms
Study design
RandomizedSingle-blind
  • Calcium Hydroxide

    Patients receiving calcium hydroxide as intra canal medicament

  • Triple Antibiotic Paste

    Patients receiving triple antibiotic paste (TAP) as intra canal medicament

03

Endpoints

Primary

  • Post Operative Pain Severity

Beyond the preview

Go deeper on NCT06821763.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06821763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call